Abstract: A covering device for protecting an anemometer engaged with an external frame on a moving body is provided. The covering device includes: a propeller protecting part including (1_1)-st and (1_2)-nd case units for protecting a propeller, wherein space created by combining the (1_1)-st and (1_2)-nd case units holds the propeller; a body protecting part including (2_1)-st and (2_2)-nd case units for protecting a main body and its vertical tail, wherein space created by combining the (2_1)-st and (2_2)-nd case units holds the main body and the vertical tail; and a supporting member protecting part including (3_1)-st and (3_2)-nd case units for protecting a supporting member, wherein space created by combining the (3_1)-st and (3_2)-nd case units holds the supporting member; wherein the (3_1)-st and (3_2)-nd case units engage the external frame, to allow all the case units to be fixed.

Abstract: A covering device for protecting an anemometer engaged with an external frame on a moving body is provided. The covering device includes: a propeller protecting part including (1_1)-st and (1_2)-nd case units for protecting a propeller, wherein space created by combining the (1_1)-st and (1_2)-nd case units holds the propeller; a body protecting part including (2_1)-st and (2_2)-nd case units for protecting a main body and its vertical tail, wherein space created by combining the (2_1)-st and (2_2)-nd case units holds the main body and the vertical tail; and a supporting member protecting part including (3_1)-st and (3_2)-nd case units for protecting a supporting member, wherein space created by combining the (3_1)-st and (3_2)-nd case units holds the supporting member; wherein the (3_1)-st and (3_2)-nd case units engage the external frame, to allow all the case units to be fixed.

Abstract: The present invention relates to immune stimulating composition comprising methylated bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides. The composition of the present invention can be industrially applied the effective materials for treating cancers and adjuvant.

Abstract: Disclosed is a method for diagnosing diabetic retinopathy by a single nucleotide polymorphism of VEGF and its receptor.

Abstract: Disclosed is an adjuvant composition of the present invention including the oligodeoxynucleotides and the LPS-derived non-toxic polysaccharides as the major components.

Abstract: Disclosed is a method for diagnosing diabetic retinopathy by a single nucleotide polymorphism of VEGF and its receptor.

Abstract: The present invention relates to immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysacchararides. The composition of the present invention can be industrially applied the effective materials for treating cancers and adjuvant.

Abstract: Disclosed are composition for diagnosing a diabetes mellitus and a retinal vascular disease, a kit for diagnosing the retinal vascular disease including the protein, a gene encoding the protein, and a method for analyzing an antibody prepared by the diabetes mellitus and/or the retinal vascular disease using the same.

Abstract: This invention relates to Cell supernatant protein for inducing angiogenesis-1 secretion. The protein of the invention can be useful as therapeutic agent for angiogenesis-related diseases.

Abstract: Disclosed is a composition comprising an aldolase protein for diagnosing retinal vascular disease. Also, the present invention discloses a kit comprising the protein for diagnosing retinal vascular disease, and a method for diagnosing retinal vascular disease comprising bringing a blood sample into contact with the aldolase protein and quantitatively analyzing formed antigen-antibody complexes.

Abstract: The present invention relates to immune stimulating composition comprising methylated bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides. The composition of the present invention can be industrially applied the effective materials for treating cancers and adjuvant.

Abstract: Composition for preventing the formation of new scar, e.g. myofibroblast, having BMP-7 polypeptide is disclosed. The composition for preventing the formation of scar includes an effective amount of BMP-7 (Bone Morphogenic Protein-7) polypeptide of sequence 1. The effective amount is 50 ng/ml-50 ?g/ml or 0.1 ng-1 ?g/kg by weight and the scar is a corneal scar.

Abstract: The present invention relates to a binding apparatus 32, installed it a closure for optical fiber cable splice, comprising an internal binding portion 34a having a first groove 36a, that narrows to the center, on the upside of an end of the closure cover 30 cut lengthwise and a skirt cover 37 for covering a skirt 38 formed at the opposite end of the closure cover 30 cut lengthwise; an external binding portion 34b having a second groove 36b, that narrows to the center corresponding to the first groove 36a, on the downside of the opposite end of the closure cover 30 cut lengthwise, and a skirt 38 inserted into the skirt cover 37 of the internal binding portion 34a; wedge-shaped bars 50a and 50b, inserted through both ends of holes formed by the first and second grooves 36a and 36b when they come in contact with each other to hold both ends of the internal and external binding portions 34a and 34b, having a clamping bar hole 52 perforated lengthwise through the middle of the bar; and a fixing means for fixing th